Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Current issue
Archive
Authors
Podcasts
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Current issue
Archive
Authors
Podcasts
About
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 81, Issue 7
Efficacy and safety of SARS-CoV-2 revaccination in non-responders with immune-mediated inflammatory disease
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Epidemiology
Efficacy and safety of SARS-CoV-2 revaccination in non-responders with immune-mediated inflammatory disease
Online download statistics by month:
Online download statistics by month: November 2021 to April 2023
Abstract
Full
Pdf
Nov 2021
673
653
221
Dec 2021
1103
1075
353
Jan 2022
489
487
158
Feb 2022
183
184
69
Mar 2022
214
209
93
Apr 2022
194
188
33
May 2022
134
134
40
Jun 2022
498
499
93
Jul 2022
231
235
56
Aug 2022
136
140
32
Sep 2022
131
137
49
Oct 2022
103
104
37
Nov 2022
104
104
25
Dec 2022
72
75
16
Jan 2023
86
87
29
Feb 2023
72
69
13
Mar 2023
71
67
27
Apr 2023
189
5
5
Total
4683
4452
1349
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
PDF